Advancing our understanding of the brain's complex circuitry

The physical and biological complexity of the human brain has posed a significant challenge in the success of neuroscience research and development. As critical as it is to develop solutions that reach the clinic, it also imperative that we enhance our basic understanding of the human brain in health and disease so that we can develop tools and approaches that increase our efficiency and chances of successful discovery and therapies.

Defining the future of neuroscience discovery
We seek to develop approaches that can enable and enhance our understanding of the brain, the nervous system and brain disease mechanisms, in an organized, systematic and effective way.

Play Video
3D spatial transcriptomics may hold clues to future therapies for brain diseases. The technique measures gene expression from the RNA found in cells. It tells us what type of cell it is, exactly where it is, and can also indicate how a cell may interact with neighboring structures to the sides, above or below. Imaging performed with spinning disk microscopy.

To that end, part of our research efforts and collaborations are focused on achieving large scale, high-content brain circuit mapping of both basic and clinical relevance. Benefiting from major advances in chemistry and genetics, we seek to help advance new methods for brain mapping and contribute to the world’s ability to see the brain in full molecular and cellular detail. 

This should have implications for all areas of basic and applied neuroscience, and should directly inform potential new therapies, whether drug- based, gene therapy- based or device- based. Hence, we also pursue the development of highly specific gene or cell therapies for specific indications such as dementia, stroke and spinal cord injury. 

Key neurobiology areas of development at the Wyss Center:

  • Brain mapping: tissue processing / histology, genetic engineering, hardware, human tissue slice culture, organoids, computational analysis and image processing
  • Molecular biology and microscopy
  • Cell and gene therapy: collaborating with external research groups and facilities on the development and optimization of pre-clinical and clinical protocols and trials 
  • Data collection and management 
  • Obtaining and banking human tissue samples

Our existing facilities and expertise in microscopy, histology and cell culture, and molecular biology will contribute to our expansion into the field of neurobiology. 

Play Video

Expanding our understanding of the brain

Expansion microscopy increases the size of brain samples, allowing intricacies to be visualized, revealing disease mechanisms.

Play Video

Revealing 3D anatomy with lightsheet microscopy

Developers around the world are pushing microscope technology to the extremes. Lightsheet microscopes image brain tissue down to individual neurons and offer unprecedented maps of nervous system structure and function.

Play Video

Creating elastic brains

The ELAST technique can help fluorescent tags penetrate samples more deeply making structures in thicker brain sections visible under a microscope.



Gaël Barthet, PhD

Director of Neuroscience

Laura Batti, PhD

Microscopy Facility Manager

Corinne Brana, PhD

Neurobiology Lab Manager

Michalina Gora, PhD

Manager in Neurophotonics

Clémence Hurni, PhD

Staff Scientist in 3D Transcriptomics

Tomas Jorda, PhD

Collaborator, UNIGE

Samira Osterop, MSc

Neurobiology Research Associate

Stéphane Pagès, PhD

Director of Neuroimaging

Tom Hutson, PhD

Group Leader
A new model of cooperation and collaboration to accelerate translational research and development in the field of neurotechnology and artificial intelligence.


Gene therapy to boost rehabilitation success following spinal cord injury.


The STAR team is pursuing new strategies, focused on astrocytes, to identify biomarkers and new therapeutic targets to treat neurological and psychiatric disorders.
Wyss Center


Join us for a fascinating journey through the gut and brain as we learn more about the enteric nervous system and discover the latest strategies to restore gut function.
Wyss Center


The collaboration will accelerate the testing of GliaPharm’s lead molecules in preclinical models of Alzheimer’s disease and further the development of neuroimaging biomarkers



State-of-the-art advanced lightsheet imaging center
A new view of glioblastoma could help predict patient outcomes